News Headlines

Display #
Title
Republicans revamp U.S. health bill, boost benefits to older Americans
Hospitals have lower death rates during surprise inspections
Republicans revamp Obamacare bill
First patient cured of rare blood disorder
Heat Biologics Rockets as Lung Cancer Med Hits Mid-Stage Goals
Merck Accelerator hits new peak of applications
Facebook Hiring Dozens for Secretive Division, Rumored to be Working on Brain-Scanning Technology and Other Med Device
Sanofi Announces Results of First-of-Its-Kind Social Experiment Revealing Real-Life Impact of Symptoms on Allergy Sufferers in the U.S.
Esperion Hits A New High After Positive Feedback For Its Heart Drug From The FDA
Harvoni Study: 97% of Hep C Patients Cured
Dietary anti-cancer compound may work by influence on cellular genetics
Human antibody for Zika virus promising for treatment, prevention
AstraZeneca and Circassia enter strategic collaboration in respiratory disease
FDA Deals Another Blow to AstraZeneca’s Blood Drug
Crippled Bay Area Pharma Threshold Rockets on Reverse Merger Deal With Molecular Templates
Biogen Faces Biggest One-Day Drop
Circassia strikes deal with AstraZeneca for respiratory drugs
Indian drugmakers face squeeze in U.S. healthcare market
Medtronic heart valve replacement succeeds in intermediate-risk patients: study
Landmark outcomes study shows that Repatha® (Evolocumab) decreases LDL-C to unprecedented low levels and reduces risk of cardiovascular events
Amgen cholesterol drug cuts heart attack, stroke risk but shares fall
Drug combination delivered by nanoparticles may help in melanoma treatment
Johnson & Johnson reports that investigational Ebola vaccine regimen induced durable immune response 1 year after vaccination in Phase 1 study
Americans Spent More Than $15 Billion On Aesthetic Procedures For The First Time Ever
GSK files for new Fluarix Quadrivalent indication
U.S. government reports decline in Obamacare individual enrollment
Patients left blind after paying for experimental stem cell treatment
China Food and Drug Administration Approves Xeljanz
FDA product review fees may double or more
European Approval for Label Extension of Cinryze